[The development of resistance must be monitored--gonococci as an example]

Tidsskr Nor Laegeforen. 2014 Mar 11;134(5):507-8. doi: 10.4045/tidsskr.14.0033.

[Article in Norwegian]

Authors

Kjetil K Melby, Anne O Olsen, Lumnije Dedi, Peter Gaustad, Gaute Syversen, Harald Moi

PMID: 24621906
DOI: 10.4045/tidsskr.14.0033

No abstract available

MeSH terms

Anti-Bacterial Agents / pharmacology
Drug Resistance, Bacterial*
Drug Utilization / standards
Humans
Neisseria gonorrhoeae / drug effects*
Sentinel Surveillance

Substances

Anti-Bacterial Agents